Shanghai Xiao Fang Pharmaceutical Co., Ltd. Class ASSE: 603207

Announcement on Lifting Sales Restrictions and Listing for Circulation in the 1st Restriction Lifting Period for the 1st Grant under 2025 Restricted Stock Incentive Plan

· Issued by Shanghai Xiao Fang Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Lifting Sales Restrictions and Listing for Circulation in the 1st Restriction Lifting Period for the 1st Grant under 2025 Restricted Stock Incentive Plan

The total number of shares to be listed and circulated this time is 202,946; the listing and circulation date is June 15, 2026.



The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis